Nymox Pharmaceutical Corp ROIC
What is the ROIC of Nymox Pharmaceutical Corp?
The ROIC of Nymox Pharmaceutical Corp is -238.41%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Nymox Pharmaceutical Corp
What does Nymox Pharmaceutical Corp do?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Companies with roic similar to Nymox Pharmaceutical Corp
- Annovis Bio has ROIC of -243.15%
- Crown ElectroKinetics has ROIC of -242.81%
- AzurRx BioPharma Inc has ROIC of -242.21%
- Caeneus Minerals Ltd has ROIC of -242.07%
- Yield10 Bioscience Inc has ROIC of -241.08%
- EV Nickel has ROIC of -238.83%
- Nymox Pharmaceutical Corp has ROIC of -238.41%
- BioForce Nanosciences has ROIC of -238.21%
- Tryp Therapeutics has ROIC of -237.27%
- Weebit Nano has ROIC of -236.32%
- Pathfinder Minerals Plc has ROIC of -235.40%
- Highmark Interactive Inc has ROIC of -233.72%
- DynaCERT has ROIC of -233.21%